There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report) and Oric Pharmaceuticals (ORIC – Research Report) with bullish sentiments. DENTSPLY SIRONA (XRAY) Barrington analyst Michael Petusky maintained a Buy rating on DENTSPLY SIRONA today and set a price target of $53.00. The company's shares closed last Tuesday at $42.20, close to its 52-week low of $41.16. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dentsply-sirona-xray-and-oric-pharmaceuticals-oric?utm_source=advfn.com&utm_medium=referral
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Ago 2022 até Set 2022 Click aqui para mais gráficos DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Set 2021 até Set 2022 Click aqui para mais gráficos DENTSPLY SIRONA.